Opioid Use Disorder Statistics in New Jersey

Opioid Use Disorder (OUD) remains a significant public health crisis in New Jersey, affecting thousands of individuals and families across the state. The prevalence of OUD in New Jersey is notably high, with some estimates placing it above the national average, underscoring the urgent need for effective prevention, treatment, and recovery services^[7]. Understanding the scope of this issue through data is the first step toward addressing its complex causes, which include socioeconomic hardship and limited healthcare access, and mitigating its devastating consequences^[2].

Nationally, the crisis is also severe, with over 10.1 million people misusing prescription opioids in the past year and an estimated 2.1 million adults meeting the criteria for OUD^[8][9]. This widespread issue provides a critical backdrop for understanding the specific challenges and statistical realities within New Jersey.

Despite the high prevalence of OUD, many New Jersey residents face significant barriers to receiving care. Data from 2019 revealed a concerning gap, with about 40% of individuals who needed facility-based OUD treatment not receiving it^[10]. More recent figures show that approximately 30% of all individuals with OUD in the state remain untreated^[11]. This treatment gap persists despite state efforts and highlights ongoing challenges in connecting people with the services they need.

While New Jersey has a higher density of specialized treatment centers than the national average, disparities remain. Access to care is not uniform across the state, with rural communities often underserved compared to urban areas^[12]. Furthermore, insurance status plays a major role, as publicly insured patients are significantly less likely to access treatment compared to those with private insurance^[13].

Opioid Use Disorder does not affect all populations equally. In New Jersey, certain demographic groups face a higher risk. Analysis shows that low-income communities and racial or ethnic minorities are disproportionately impacted by the opioid crisis^[2]. Age is also a critical factor, with young adults representing a significant portion of OUD cases. Additionally, data on substance abuse treatment admissions reveals that heroin was the most frequently reported primary substance in 2022, indicating its continued prevalence in the state^[2].

The prevalence of Opioid Use Disorder has not been static, with data showing a concerning upward trend both in New Jersey and nationwide. This increase has been partly attributed to factors exacerbated by the COVID-19 pandemic, such as social isolation, economic distress, and disruptions to treatment access^[9]. In New Jersey, the 12-month prevalence rate among adults saw a 12% increase between 2019 and 2023^[9]. This trend highlights the persistent and evolving nature of the opioid crisis, requiring continuous monitoring and adaptation of public health strategies.

In response to the ongoing crisis, New Jersey has implemented several key initiatives aimed at expanding treatment and reducing harm. The state government has expanded its commitment to medication-assisted treatment (MAT) programs, which are considered the gold standard for OUD care^[14]. Additionally, through State Targeted Response (STR) and State Opioid Response (SOR) grants, New Jersey is actively working to address opioid and stimulant misuse^[15]. The Department of Human Services is also focused on reducing racial disparities in care and integrating substance use disorder treatments into primary care settings to improve accessibility^[16][17].